Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer

Status: Recruiting
Location: See all (44) locations...
Intervention Type: Diagnostic Test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: No
View:

• Recently diagnosed with prostate cancer for whom definitive surgical treatment is indicated

Locations
United States
Arizona
Mayo Clinic Hospital in Arizona
Recruiting
Phoenix
Mayo Clinic in Arizona
Recruiting
Scottsdale
Connecticut
Yale University
Recruiting
New Haven
Florida
Mayo Clinic in Florida
Recruiting
Jacksonville
University of Florida Health Science Center - Jacksonville
Recruiting
Jacksonville
Hawaii
Pali Momi Medical Center
Recruiting
'aiea
Straub Pearlridge Clinic
Recruiting
'aiea
Queen's Medical Center
Recruiting
Honolulu
Straub Clinic and Hospital
Recruiting
Honolulu
Iowa
University of Iowa/Holden Comprehensive Cancer Center
Recruiting
Iowa City
Illinois
Midwestern Regional Medical Center
Active, not recruiting
Zion
Indiana
Indiana University/Melvin and Bren Simon Cancer Center
Recruiting
Indianapolis
Kansas
University of Kansas Cancer Center
Recruiting
Kansas City
University of Kansas Hospital-Indian Creek Campus
Recruiting
Overland Park
Louisiana
East Jefferson General Hospital
Recruiting
Metairie
LSU Healthcare Network / Metairie Multi-Specialty Clinic
Recruiting
Metairie
Massachusetts
Brigham and Women's Hospital
Recruiting
Boston
Michigan
Henry Ford Hospital
Recruiting
Detroit
Spectrum Health at Butterworth Campus
Recruiting
Grand Rapids
Henry Ford West Bloomfield Hospital
Recruiting
West Bloomfield
Minnesota
Mayo Clinic in Rochester
Recruiting
Rochester
Missouri
Mercy Hospital Saint Louis
Recruiting
Saint Louis
Washington University School of Medicine
Suspended
Saint Louis
North Carolina
UNC Lineberger Comprehensive Cancer Center
Recruiting
Chapel Hill
New Hampshire
Dartmouth Hitchcock Medical Center
Recruiting
Lebanon
New York
NYP/Weill Cornell Medical Center
Recruiting
New York
Stony Brook University Medical Center
Recruiting
Stony Brook
Oregon
Rogue Valley Medical Center
Recruiting
Medford
Pennsylvania
Penn State Milton S Hershey Medical Center
Recruiting
Hershey
Fox Chase Cancer Center
Recruiting
Philadelphia
Thomas Jefferson University Hospital
Recruiting
Philadelphia
University of Pennsylvania/Abramson Cancer Center
Recruiting
Philadelphia
Tennessee
Vanderbilt University/Ingram Cancer Center
Recruiting
Nashville
Texas
MD Anderson in The Woodlands
Recruiting
Conroe
UT Southwestern/Simmons Cancer Center-Dallas
Recruiting
Dallas
M D Anderson Cancer Center
Recruiting
Houston
MD Anderson West Houston
Recruiting
Houston
MD Anderson League City
Recruiting
League City
Audie L Murphy VA Hospital
Recruiting
San Antonio
University of Texas Health Science Center at San Antonio
Recruiting
San Antonio
MD Anderson in Sugar Land
Recruiting
Sugar Land
Wisconsin
ProHealth Waukesha Memorial Hospital
Suspended
Waukesha
UW Cancer Center at ProHealth Care
Recruiting
Waukesha
West Virginia
West Virginia University Healthcare
Recruiting
Morgantown
Time Frame
Start Date: July 9, 2018
Estimated Completion Date: August 1, 2025
Participants
Target number of participants: 852
Treatments
Experimental: Diagnostic (mpMRI)
Patients undergo mpMRI within 3 months prior to schedule surgery.
Related Therapeutic Areas
Sponsors
Leads: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials